EUVIMEDEUVIMED entdecken
Systematische Übersicht

Impella 5.5: A Systematic Review of the Current Literature

Carlos Alberto Valdes iD, Ahmet Bilgili iD, Akshay Reddy, Omar Sharaf, Fabian Jimenez-Contreras, Griffin Stinson iD, Mustafa Ahmed, Juan Vilaro, Alex M Parker, Mohammad Az Al-Ani, Daniel Demos, Juan Aranda und 3 weitere

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2024-07 · 19 (4) · 380-389

DOI: 10.1177/15569845241266527 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 12.09.2024. Verfasst von Carlos Alberto Valdes und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Shock, Cardiogenic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Impella 5.5 (Abiomed, Danvers, MA, USA) is a temporary mechanical circulatory support device used for patients in cardiogenic shock. This review provides a comprehensive overview of the device’s clinical effectiveness, safety profile, patient outcomes, and relevant procedural considerations.

Methods

We conducted a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines using the PubMed/MEDLINE database. The search query included articles available from October 6, 2022, through January 13, 2023. Our initial search identified 75 studies. All records were screened by 2 independent reviewers using the Covidence software for adherence to our inclusion criteria, and 8 retrospective cohort studies were identified as appropriate for inclusion.

Results

Across the included studies, the sample size ranged from 4 to 275, with predominantly male cohorts. Indications for Impella support varied, and the duration of support ranged from 9.8 to 70 days. Overall, Impella support appeared to be associated with favorable survival rates and manageable complications in various patient populations. Complications associated with Impella use included bleeding, stroke, and device malfunctions. Two studies compared prolonged and Food and Drug Administration–approved Impella support, showing similar outcomes and adverse events.

Conclusions

Impella 5.5 continues to be an attractive option for bridging patients to definitive therapy. Survival during and after Impella 5.5 was favorable for patients regardless of initial indication. However, device use was associated with several important complications, which calls for judicious use and a precontemplated exit strategy. Limitations of this literature review include biases inherent to the retrospective studies included, such as selection and publication bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesShock, CardiogenicFemaleHumansMaleTreatment Outcome

Stichwörter der Autor:innen

Impellabridge to therapycardiogenic shockleft ventricular assist devicesmechanical circulatory support

Autor:innen und Institutionen

  • College of Medicine, University of Florida, Gainesville, FL, USA.
  • Division of Cardiovascular Surgery, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, University of Florida Health, Gainesville, FL, USA.

ORCID-Profile: Carlos Alberto Valdes, Ahmet Bilgili, Griffin Stinson

Zitieren

APA

Valdes, C. A., Bilgili, A., Reddy, A., Sharaf, O., Jimenez-Contreras, F., Stinson, G., Ahmed, M., Vilaro, J., Parker, A. M., Al-Ani, M. A., Demos, D., Aranda, J., Bleiweis, M., Beaver, T. M., & Jeng, E. I. (2024). Impella 5.5: A Systematic Review of the Current Literature. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 19(4), 380-389. https://doi.org/10.1177/15569845241266527

Vancouver

Valdes CA, Bilgili A, Reddy A, Sharaf O, Jimenez-Contreras F, Stinson G, et al. Impella 5.5: A Systematic Review of the Current Literature. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2024;19(4):380-389. doi:10.1177/15569845241266527

BibTeX
@article{Valdes2024,
  author = {Valdes, Carlos Alberto and Bilgili, Ahmet and Reddy, Akshay and Sharaf, Omar and Jimenez-Contreras, Fabian and Stinson, Griffin and Ahmed, Mustafa and Vilaro, Juan and Parker, Alex M and Al-Ani, Mohammad Az and Demos, Daniel and Aranda, Juan and Bleiweis, Mark and Beaver, Thomas M and Jeng, Eric I},
  title = {Impella 5.5: A Systematic Review of the Current Literature},
  journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
  year = {2024},
  volume = {19},
  number = {4},
  pages = {380--389},
  doi = {10.1177/15569845241266527}
}
Kostenlos starten →